World-leading translational research centres across the North have come together to showcase their ground-breaking research with industry partners to deliver the next generation of medicine.
The four Northern NIHR Biomedical Research Centres (BRCs) in Leeds, Manchester, Newcastle and Sheffield have published ‘NIHR Northern BRC Collaborative: Innovating with Industry’ supported by the Northern Health Science Alliance (NHSA).
The BRCs in the North are crucial to the success of research in the region and are leading the way in scientific discovery, developing therapeutics, diagnostics and medical technologies, running trials and working with industry.
The new brochure highlights some of the exemplary work the BRCs are doing with industry to accelerate the translation of new research for the benefit of patients, the public, and the health and care system.
The case studies showcase a wide range of activity, from early phase clinical study design, biomarker identification, developing and engineering new imaging techniques, to gene sequencing, and creating cutting edge cell and gene therapies.
Each BRC in the region provides infrastructure to support translational research across key areas of excellence: musculoskeletal in Leeds; translational medicine in Manchester; ageing and long term conditions in Newcastle; and chronic neurological disorders in Sheffield.
The NHSA works with the Northern BRC collective to build a collaborative innovation eco-system within the region, to benefit patients and drive economic growth.
Dr Séamus O’Neill, NHSA Chief Executive, said: “The NHSA is proud to be working alongside the NIHR BRCs to stimulate collaboration and celebrate their impact.
“There has never been a more appropriate time to acknowledge the value of the UK research and innovation base to the national and global life sciences sector. The BRCs are a fundamental part of that science base and the four in the North are a vital part of our clinical academic infrastructure.”